Evidence map›Paper›PMID 24951129›Full record

ArticleMaternal and child health journal2015

Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.

Ibrahim I Daud, Sidney Ogolla, Asito S Amolo, Eunice Namuyenga, Kenneth Simbiri, Elizabeth A Bukusi, Zipporah W Ng'ang'a, Robert Ploutz-Snyder, Peter O Sumba, Arlene Dent and 1 more

Open access · greenAbstract read
In one paragraph

Article in Maternal and child health journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ibrahim I DaudCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Sidney Ogolla
Asito S Amolo
Eunice Namuyenga
Kenneth Simbiri
Elizabeth A Bukusi
Zipporah W Ng'ang'a
Robert Ploutz-Snyder
Peter O Sumba
Arlene Dent
Rosemary Rochford
Kenya Medical Research Institute · KEJomo Kenyatta University of Agriculture and Technology · KESUNY Upstate Medical University · USCenter for Global Health · USJaramogi Oginga Odinga University of Science and Technology · KEUniversities Space Research Association · US

Funding

Effects of Malaria on EBV Persistence in ChildrenR01CA102667 · NCI · UPSTATE MEDICAL UNIVERSITY · PI ROCHFORD, ROSEMARY · 2005 to 2014
$2.9M
B cell immunity in HIV exposed uninfected infants in KenyaR01AI098511 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI DENT, ARLENE · 2012 to 2015
$2.5M
NCI NIH HHS CA102667NCI NIH HHS R01 CA102667NIAID NIH HHS AI 098511NIAID NIH HHS R01 AI098511
6 · The paper itself

Abstract

The role of Plasmodium falciparum malaria in Epstein-Barr virus (EBV) transmission among infants early in life remain elusive. We hypothesized that infection with malaria during pregnancy could cause EBV reactivation leading to high EBV load in circulation, which could subsequently enhance early age of EBV infection. Pregnant women in Kisumu, where P. falciparum malaria is holoendemic, were actively followed monthly through antenatal visits (up to 4 per mother) and delivery. Using real-time quantitative (Q)-PCR, we quantified and compared EBV and P. falciparum DNA levels in the blood of pregnant women with and without P. falciparum malaria. Pregnant women that had malaria detected during pregnancy were more likely to have detectable EBV DNA than pregnant women who had no evidence of malaria infection during pregnancy (64 vs. 36 %, p = 0.01). EBV load as analyzed by quantifying area under the longitudinal observation curve (AUC) was significantly higher in pregnant women with P. falciparum malaria than in women without evidence of malaria infection (p = 0.01) regardless of gestational age of pregnancy. Increase in malaria load correlated with increase in EBV load (p < 0.0001). EBV load was higher in third trimester (p = 0.04) than first and second trimester of pregnancy independent of known infections. Significantly higher frequency and elevated EBV loads were found in pregnant women with malaria than in women without evidence of P. falciparum infection during pregnancy. The loss of control of EBV latency following P. falciparum infection during pregnancy and subsequent increase in EBV load in circulation could contribute to enhanced shedding of EBV in maternal saliva and breast milk postpartum, but further studies are needed.

Indexed as

AdultDNA, ProtozoanDNA, ViralEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansMalaria, FalciparumParasitemiaPlasmodium falciparumPregnancyPregnancy Complications, InfectiousPregnant PeopleReal-Time Polymerase Chain ReactionViral LoadDNA, ProtozoanDNA, Viral

Identifiers

PMID24951129
PMCPMC4272914
OpenAlexW2045109526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.